SEC Filings TLDR

On October 23, 2025, Noah Popp, EVP, GC, and Secretary of Enerpac Tool Group Corp, acquired 3,240 restricted stock units (RSUs) in the company. These RSUs were granted under the Enerpac Tool Group 2017 Omnibus Plan and will vest in three equal annual installments starting on October 23, 2026. Following this transaction...

On October 23, 2025, Darren Matthew Kozik, EVP & CFO of Enerpac Tool Group Corp, acquired 6,774 shares of Class A Common Stock at a price of $0 per share. This acquisition was part of restricted stock units granted under the Enerpac Tool Group 2017 Omnibus Plan, which vest in three equal annual installments beginning o...

On October 23, 2025, Eric Theodore Chack, Executive Vice President of Operations at Enerpac Tool Group Corp, acquired 3,829 shares of Class A Common Stock. This transaction was part of restricted stock units granted under the Enerpac Tool Group 2017 Omnibus Plan, which vest in three equal annual installments beginning ...

Ezra Uzi Yemin, a director of Delek US Holdings, Inc., sold a significant number of shares in the company over three days in October 2025. The transactions were executed under a Rule 10b5-1 plan, indicating they were pre-planned. On October 23, Yemin sold 7,249 shares directly and 26,578 shares indirectly through Yemin...

Philip Watkins, EVP and Head of Corporate Development at Customers Bancorp, Inc., sold 3,763 shares of common stock on October 24, 2025, at a price of $70.11 per share. The shares were withheld for taxes upon the vesting of a previously issued restricted stock award. Following this transaction, Watkins owns 53,749 shar...

Yuval Cohen, the Chief Executive Officer of Corbus Pharmaceuticals Holdings, Inc., engaged in several stock transactions between October 24 and October 27, 2025. Cohen acquired 18,660 shares of common stock at $4.26 per share and subsequently sold the same number of shares at $17.01 per share on October 24. On October ...

On October 24, 2025, Sean Moran, the Chief Financial Officer of Corbus Pharmaceuticals Holdings, Inc., engaged in several stock transactions. Moran acquired 12,981 shares of common stock at $4.26 per share, increasing his total holdings to 86,294 shares. On the same day, he sold 12,981 shares at a weighted average pric...

On October 23, 2025, Myron Kaplan, a director of CorMedix Inc., purchased 25,000 shares of the company's common stock at a weighted average price of $11.02 per share. This transaction increased his direct ownership to 201,034 shares. Additionally, Kaplan indirectly owns 20,000 shares through his spouse and 10,000 share...

On October 27, 2025, Accardi Mario Alberto, President of the Orexin Program at Centessa Pharmaceuticals plc, engaged in several transactions involving the company's Ordinary Shares. He acquired 5,000 shares at $8.01 per share and disposed of 8,000 shares at $25.00 per share. The sales were executed under a Rule 10b5-1 ...

On October 27, 2025, Wendell Wierenga, a director of Cytokinetics Inc, engaged in several stock transactions. He acquired 4,375 shares of common stock at $10.00 per share and subsequently disposed of the same number of shares at $58.68 per share. Additionally, he exercised a non-qualified stock option to buy 4,375 shar...

On October 25, 2025, Ericka Lynn Pullin, the GEVP of Culture & People Development at Cullen/Frost Bankers, Inc., engaged in several stock transactions. She acquired 384 shares of common stock through a transaction coded as 'M' and disposed of 93 shares at a price of $124.86 per share through a transaction coded as 'F'....

Matthew Bradley Henson, the Chief Accounting Officer of Cullen/Frost Bankers, Inc., reported several stock transactions on October 25, 2025. He acquired 419 shares of Common Stock at $0.00 per share and disposed of 102 shares at $124.86 per share, resulting in a post-transaction ownership of 317 shares. Additionally, h...

On October 25, 2025, Dan Geddes, the GEVP & Chief Financial Officer of Cullen/Frost Bankers, Inc., engaged in several transactions involving the company's common stock. Geddes acquired 1,049 shares of common stock through a transaction coded as 'M', with no price per share reported, increasing his direct ownership to 3...

Howard L. Kasanoff, GEVP Chief Credit Officer of Cullen/Frost Bankers, Inc., reported several transactions involving the company's common stock and restricted stock units (RSUs) on October 25, 2025. Kasanoff acquired 1,073 shares of common stock at $0 per share, increasing his direct holdings to 4,043 shares. He also d...

On October 25, 2025, Coolidge E. Rhodes Jr., Group EVP General Counsel/Sec of Cullen/Frost Bankers, Inc., engaged in several transactions involving the company's common stock and restricted stock units. Rhodes acquired 2,097 shares of common stock at $0 per share, increasing his direct holdings to 5,320 shares. He also...

On October 25, 2025, Carol J. Severyn, GEVP and Chief Risk Officer of Cullen/Frost Bankers, Inc., engaged in several stock transactions. She acquired 2,045 shares of common stock through a transaction coded as 'M' and disposed of 804 shares at a price of $124.86 per share through a transaction coded as 'F'. Additionall...

On October 25, 2025, Jimmy Stead, GEVP Chief Consumer Banking of Cullen/Frost Bankers, Inc., engaged in several stock transactions. He acquired 2,621 shares of common stock at $0.00 per share, increasing his direct holdings to 17,639 shares. Additionally, he disposed of 1,031 shares at $124.86 per share, reducing his d...

Annette M. Alonzo, GEVP Chief HR Officer of Cullen/Frost Bankers, Inc., reported several transactions involving the company's common stock and restricted stock units on October 25, 2025. Alonzo acquired 1,992 shares of common stock at $0.00 per share, increasing her direct holdings to 19,832 shares. She also disposed o...

Paul Bracher, President of CFR, reported several transactions involving Cullen/Frost Bankers, Inc. (CFR) common stock and restricted stock units on October 25, 2025. Bracher acquired 2,796 shares of common stock at $0 per share, increasing his direct holdings to 108,064 shares. He also disposed of 1,100 shares at $124....

On October 25, 2025, Bobby Berman, the GEVP of Research & Strategy at Cullen/Frost Bankers, Inc., engaged in several transactions involving the company's common stock and restricted stock units. Berman acquired 1,573 shares of common stock at $0 per share, increasing his total holdings to 29,856 shares. On the same day...

Phillip D. Green, Chairman and CEO of Cullen/Frost Bankers, Inc., reported several stock transactions on October 25, 2025. Green acquired 11,097 shares of common stock at $0.00 per share and disposed of 4,366 shares at $124.86 per share. Following these transactions, Green directly owned 108,188 shares of common stock....

On October 24, 2025, Daniel K. Schlanger, EVP and CTO of Crown Castle Inc., sold 30,000 shares of the company's common stock at a weighted average price of $98.0765 per share. The sales were conducted through various transactions with prices ranging from $97.700 to $98.490. Following this transaction, Schlanger's direc...

On October 24, 2025, Edward G. Canup, the Chief Banking Officer of Colony Bankcorp, Inc., acquired 500 shares of the company's common stock at a price of $16.587 per share. Following this transaction, Canup directly owns 17,266.63 shares. Additionally, Canup indirectly owns 7,775 shares through a 401K plan, which inclu...

Max R. Levchin, a director of Coca-Cola Co, purchased shares of the company's common stock in multiple transactions between October 23 and October 24, 2025. On October 23, Levchin acquired 2,864 shares at a weighted average price of $69.8721 and 4,197 shares at a weighted average price of $70.3062. On October 24, he pu...

Joseph E. Creed, the Chief Executive Officer of Caterpillar Inc., reported a transaction involving phantom stock units under the company's non-qualified deferred compensation plan. On October 24, 2025, Creed acquired 29 phantom stock units at a price of $522.73 per unit, equivalent to one share of Caterpillar Inc. comm...